These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22029138)

  • 1. ["Of snakes and crocodiles": central side effects of nose drops and facts about rhinitis medicamentosa].
    Bielenberg J
    Kinderkrankenschwester; 2011 Oct; 30(10):406-8. PubMed ID: 22029138
    [No Abstract]   [Full Text] [Related]  

  • 2. ["Of snakes and crocodiles". Central side effects caused by nose drops].
    Bielenberg J
    HNO; 1998 Mar; 46(3):276-80. PubMed ID: 9583036
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.
    Graf P
    Rhinology; 1996 Mar; 34(1):9-13. PubMed ID: 8739860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended use of topical nasal decongestants.
    Yoo JK; Seikaly H; Calhoun KH
    Laryngoscope; 1997 Jan; 107(1):40-3. PubMed ID: 9001263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ultrastructural changes in human nasal mucosa in rhinitis medicamentosa].
    Knipping S; Holzhausen HJ; Riederer A; Bloching M
    HNO; 2006 Oct; 54(10):742-8. PubMed ID: 16477462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis].
    Dorn M; Hofmann W; Knick E
    HNO; 2003 Oct; 51(10):794-9. PubMed ID: 14523532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rhinitis medicamentosa, an increasing problem. Do nose drops adversely affect bacterial infections?].
    Wilhelmson B
    Lakartidningen; 1994 Dec; 91(49):4635-6. PubMed ID: 7808178
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual hallucinations in children receiving decongestants.
    Sankey RJ; Nunn AJ; Sills JA
    Br Med J (Clin Res Ed); 1984 May; 288(6427):1369. PubMed ID: 6201227
    [No Abstract]   [Full Text] [Related]  

  • 10. One year follow-up of patients with rhinitis medicamentosa after vasoconstrictor withdrawal.
    Graf PM; Hallén H
    Am J Rhinol; 1997; 11(1):67-72. PubMed ID: 9065350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal respiratory distress from rhinitis medicamentosa.
    Osguthorpe JD; Shirley R
    Laryngoscope; 1987 Jul; 97(7 Pt 1):829-31. PubMed ID: 2439862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic hallucinosis from nasal drops.
    Escobar JI; Karno M
    JAMA; 1982 Apr; 247(13):1859-60. PubMed ID: 6174744
    [No Abstract]   [Full Text] [Related]  

  • 14. Paranasal sinusitis after long-term use of topical nasal decongestants.
    Min YG; Kim HS; Suh SH; Jeon SY; Son YI; Yoon S
    Acta Otolaryngol; 1996 May; 116(3):465-71. PubMed ID: 8790749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis.
    Baroody FM; Brown D; Gavanescu L; DeTineo M; Naclerio RM
    J Allergy Clin Immunol; 2011 Apr; 127(4):927-34. PubMed ID: 21377716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.
    Cam B; Sari M; Midi A; Gergin O
    Eur Arch Otorhinolaryngol; 2019 Nov; 276(11):3123-3130. PubMed ID: 31468129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe maculopapular eruption due to pseudoephedrine in a combination drug, with cross-reactivity to phenylephrine.
    Gratacós Gómez AR; González Jimenez OM; Palacios Cañas A; Moreno Lozano L; Juan Cencerrado M; Gómez Torrijos E
    Contact Dermatitis; 2021 Dec; 85(6):716-717. PubMed ID: 34313328
    [No Abstract]   [Full Text] [Related]  

  • 18. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension induced by a nasal decongestant. Value of the use of an automatic and programmable recording technic].
    Balansard P; Mathieu F; Normand P; Frances Y; Luccioni R
    Sem Hop; 1983 Dec; 59(44):3059-61. PubMed ID: 6198723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with xylometazoline (Otrivin) nosedrops over a six-week period.
    Petruson B
    Rhinology; 1981 Sep; 19(3):167-72. PubMed ID: 6171024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.